The average net positivity score for the Big Four was higher in the second quarter than it has been in at least a year. Click ...

Integra LifeSciences’ second quarter results reflected steady execution amid ongoing operational transformation efforts.

Net cash used in operating activities (GAAP) was $1,400,000 in fiscal Q2 2025, compared to $3,700,000 provided in fiscal Q2 ...

Revenue -- Revenue (GAAP) totaled approximately $1.25 million for the six months ended June 30, 2025, down from $1.75 million ...

Rigel's Q2 results highlight soaring revenue and raised guidance for 2025. See more on RIGL stock's growth potential, ...

Looking back on automobile manufacturing stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including ...

Taiwan's Foxconn, the world's largest contract electronics maker, posted a 27% rise in second-quarter profit, beating market ...

Euroseas (ESEA) delivered earnings and revenue surprises of +8.53% and +0.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

CoreWeave reports strong Q2 revenue and issues upbeat future guidance. Here's why CRWV shares still tanked following the ...

Key Points Revenue (GAAP) of $13.0 million for Q2 FY2025 exceeded estimates by 9.7%, reflecting robust sequential growth from $9.7 million in Q1 FY2025. Gross margin (GAAP) fell sharply to 38.5% in Q2 ...

Chief Financial Officer Barry Berlin reported, "Our FFO was negative $7.9 million or negative $10.42 per diluted share compared to negative $3.3 million or negative $3.46 per diluted share in the ...

Gilead Sciences delivered a better-than-expected second quarter, propelled by the strong performance of its HIV portfolio and ...